Cigna Corp (CI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cigna Corp stock (CI) is currently trading at $270.36. Cigna Corp PE ratio is 11.99. Cigna Corp PS ratio (Price-to-Sales) is 0.26. Analyst consensus price target for CI is $338.80. WallStSmart rates CI as Hold.
- CI PE ratio analysis and historical PE chart
- CI PS ratio (Price-to-Sales) history and trend
- CI intrinsic value — DCF, Graham Number, EPV models
- CI stock price prediction 2025 2026 2027 2028 2029 2030
- CI fair value vs current price
- CI insider transactions and insider buying
- Is CI undervalued or overvalued?
- Cigna Corp financial analysis — revenue, earnings, cash flow
- CI Piotroski F-Score and Altman Z-Score
- CI analyst price target and Smart Rating
Cigna Corp
📊 No data available
Try selecting a different time range
CI Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Cigna Corp (CI)
CI trades 79% above its Graham fair value of $150.76, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Cigna Corp (CI) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, price/sales. Concerns around operating margin and eps growth. Fundamentals are solid but monitor weak areas for improvement.
Cigna Corp (CI) Key Strengths (6)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
91.63% of shares held by major funds and institutions
Large-cap company with substantial market presence
Trading at 1.66x book value, attractively priced
Solid profitability: $15 profit per $100 equity
Supporting Valuation Data
Cigna Corp (CI) Areas to Watch (4)
Earnings declining -9.30%, profits shrinking
Near-zero operating margins, business under pressure
Very thin margins, barely profitable
Solid revenue growth at 10.40% per year
Cigna Corp (CI) Detailed Analysis Report
Overall Assessment
This company scores 63/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 6 register as strengths (avg 9.0/10) while 4 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.76), Price/Sales (0.26), Price/Book (1.66) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 15.10%.
The Bear Case
The primary concerns are EPS Growth, Operating Margin, Profit Margin. Growth concerns include Revenue Growth at 10.40%, EPS Growth at -9.30%, which may limit upside. Profitability pressure is visible in Operating Margin at 3.53%, Profit Margin at 2.17%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 15.10% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 10.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (EPS Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CI's Price-to-Sales ratio of 0.26x trades at a deep discount to its historical average of 0.85x (4th percentile). The current valuation is 91% below its historical high of 2.9x set in May 2007, and 43% above its historical low of 0.18x in Nov 2008.
WallStSmart Analysis Synopsis
Data-driven financial summary for Cigna Corp (CI) · HEALTHCARE › HEALTHCARE PLANS
The Big Picture
Cigna Corp is a mature, profitable business with steady cash generation. Revenue reached 274.9B with 10% growth year-over-year. Profit margins are strong at 217.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 1510.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 217.0% and operating margin of 353.0% demonstrate strong pricing power and operational efficiency.
What to Watch Next
Sector dynamics: monitor HEALTHCARE PLANS industry trends, competitive moves, and regulatory changes that could impact Cigna Corp.
Bottom Line
Cigna Corp is a well-established business delivering consistent profitability with 217.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(36 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:21:27 AM
About Cigna Corp(CI)
NYSE
HEALTHCARE
HEALTHCARE PLANS
USA
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).